Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Journal of diabetes and its complications • 2012 | View Paper
“In parallel, AG treatment increased eNOS mRNA and protein levels along with the reduced immunoreactivity of nitrotyrosine in rabbit basilar arteries.”
Proceedings of the National Academy of Sciences of the United States of America • 2006 | View Paper
“Aminoguanidine AG ), a selective inhibitor of inducible nitric oxide synthase (iNOS), inhibited LPS-induced increase in fluorescent intensity of NT in BPAECs.”
Sheng li xue bao : [Acta physiologica Sinica] • 2003 | View Paper
“Early treatment of animals with aminoguanidine , a relatively selective inhibitor of NOS‐II, lowered nitrotyrosine immunoreactivity but at the same time led to more severe disease and pronounced inflammatory infiltrates in the lumbar spinal cord.”
American journal of physiology. Lung cellular and molecular physiology • 2000 | View Paper
“Likewise, the increase of iNOS expression, nitrotyrosine immunostaining, nitric oxide production and superoxide anion formation in adult SHR were also significantly suppressed by chronic treatment with PDTC and aminoguanidine.”